Life saving surgical technique to be pioneered in Yorkshire

October 23, 2012

A surgical technique which could save the lives of 3,000 colon cancer patients every year will be taught to Yorkshire's surgeons this week in a bid to improve outcomes.

Researchers at the Leeds Institute of Molecular Medicine, part of the University of Leeds' School of Medicine, have spent the past 15 years studying photographic records of bowel removed in the city and around the world in order to compare different types of surgery and how they relate to curing patients.

Initial research into tumours located in the rectum, undertaken by Professor Phil Quirke, led to two training programmes for rectal involving 200 English NHS hospitals. Following further research into tumours located in the colon by Dr Nick West and Professor Quirke, the team will now trial a new training programme in Yorkshire – the first of its kind in the county. If the course, funded by Yorkshire Cancer Research, is successful, it could be rolled out across the UK.

There are 25,000 cases of colon cancer diagnosed in the country each year, and while survival rates for both colon and rectal cancer are slowly improving, colon cancer now has the worst prognosis and the programme aims to change this. New studies by Dr Eva Morris, also from the University of Leeds, have shown a wide variation not only in cure rates but also in death rates after surgery, and her findings will be presented during the two-day course.

Professor Quirke said: "There is wide variation in outcomes for patients with colon cancer across the UK and beyond. Previous studies have shown that by standardising surgery and removing much more tissue surrounding the tumour and ensuring that the specimen removed is more intact, the chance of survival can be increased by 15%.

"Yorkshire currently sits in the middle of the field for outcomes in colon cancer. We would like to improve our position so that we become one of the best in England. We are bringing global leaders in the area to Leeds to share their experiences with surgeons and pathologists and see if we can benefit from their work."

The course will include a presentation by Professor Werner Hohenberger, who is based in Erlangen, Germany, where survival rates are 20% higher than in the UK. Following studies on surgical specimens from Leeds, Dr West compared them to samples from Erlangen, Japan and Denmark and discovered major differences between surgeons and centres.

A training programme based on Hohenberger's technique was recently implemented in Denmark, which has the highest mortality rate for the disease in Western Europe. Based on Dr West's findings, the Danish health authorities carried out a complete retraining of all teams involved in bowel cancer treatment, and although it will be another three years before the impact on five year survival rates is known, the programme proved that clinical practice could be altered through training.

Surgeons from Hillerod Hospital in Denmark and Karolinska University Hospital in Stockholm, who have adopted the technique, will also present as part of the course.

Professor Quirke added: "If we can convince Yorkshire's surgeons to focus on and pioneer these techniques, we will then be able to go to the English NHS with conclusive data from both Denmark and Yorkshire and show them that surgical education could have a major impact on in this country and beyond. If every surgeon in the UK took up this technique, we estimate that 3,000 lives could be saved every year. We wish to ensure that the latest techniques are brought Yorkshire to the benefit Yorkshire patients and ultimately patients elsewhere and thanks to Yorkshire Cancer Research we are able to do so."

Explore further: New study moves researchers closer to lung cancer blood test

Related Stories

New study moves researchers closer to lung cancer blood test

October 15, 2012
Early signs of lung cancer could be diagnosed using a simple blood test following a new discovery by scientists at the University of York.

Elderly breast cancer patients less likely to get surgery

June 17, 2011
(PhysOrg.com) -- University of Manchester researchers, working with colleagues in York, Leeds and Hull, looked at the records of more than 23,000 women with breast cancer diagnosed in the West Midlands, Yorkshire and North ...

Recommended for you

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One-size treatment for blood cancer probably doesn't fit all, researchers say

November 22, 2017
Though African-American men are three times more likely to be diagnosed with a blood cancer called multiple myeloma, most scientific research on the disease has been based on people of European descent, according to a study ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

Combination immunotherapy targets cancer resistance

November 22, 2017
Cancer immunotherapy drugs have had notable but limited success because in many cases, tumors develop resistance to treatment. But researchers at Yale and Stanford have identified an experimental antibody that overcomes this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.